News Funding from The Michael J. Fox FoundationNews, Press Release Priavoid closes financing roundNews, Press Release Sprunginnovationsprojekt geht neue Wege in der Alzheimer-TherapieNews, Press Release Alzheimer´s Research: Important Milestone for PRI-002News, Press Release Nobel Prize winner Stanley Prusiner joins Priavoid’s supervisory boardNews, Press Release New CEO of PriavoidNews Priavoid Headquarters at LSC DüsseldorfNews Seed InvestmentNews Prof. Willbold´s interview with PharmaVenturesNews Clinical trial with PRI-002News Contact usPlease use our contact form if you require any information. Contact form
